Putin signed a decree approving the new version of Russia's nuclear deterrence policy, causing safe-haven assets to rise.
Putin signs decree approving the new version of Russia's national policy on nuclear deterrence, and safe-haven assets rebound significantly.
On Tuesday, safe-haven assets rebounded significantly after Russian President Putin signed a decree approving a new version of Russia's basic policy on nuclear deterrence. The decree took effect on the day of signing. Following Putin's approval of the updated nuclear principles on Tuesday, investors rushed to buy government bonds, yen, and gold. German bond yields fell by as much as 8 basis points to 2.292% on that day, gold reached a daily high of around $2626 per ounce, and the USD fell by 0.9% against the yen to 153.28. The European aerospace and defense sector index fell by 0.6% after opening, but later recovered some lost ground, with a decline of 0.2% at the time of writing.
Related Articles

Ryan Capital: Over the past 24 months, a total of 58 securities firms have participated in the sponsorship work of 172 newly listed companies in Hong Kong.

The Hong Kong dollar interbank interest rates all fell, with the one-month interbank interest rate falling for three consecutive days to 3.16131%.

HKEX: The third quarter trading volume of Stock Connect increased by 25% compared to the previous quarter.
Ryan Capital: Over the past 24 months, a total of 58 securities firms have participated in the sponsorship work of 172 newly listed companies in Hong Kong.

The Hong Kong dollar interbank interest rates all fell, with the one-month interbank interest rate falling for three consecutive days to 3.16131%.

HKEX: The third quarter trading volume of Stock Connect increased by 25% compared to the previous quarter.

RECOMMEND

World’s largest oil company Aramco posts higher Q3 net profit after lifting output
04/11/2025

HSBC, General Atlantic CEOs flag AI capex-revenue mismatch, ‘irrational exuberance’
04/11/2025

Pfizer Files Second Lawsuit Against Novo Nordisk and Metsera Amid Intensifying Bidding Battle Over Obesity Biotech
04/11/2025


